Jiangsu Hengrui Pharmaceuticals (01276) recommends adopting the 2026 A-share employee stock ownership plan.

21:44 19/08/2026

Hengrui Medicine (01276) announced that the board of directors has approved the employee stock ownership plan at the board meeting held on August 19, 2026. The employee stock ownership plan will take effect only after being reviewed and approved by the company's shareholders' meeting.

Jiangsu Hengrui Pharmaceuticals (01276) announced in a notice that its Board of Directors has approved the employee stock ownership plan during a board meeting held on August 19, 2026. The implementation of the employee stock ownership plan is subject to approval by the company's shareholders' meeting before taking effect. The purpose of this plan is to establish and improve the mechanism for sharing the interests of the company, shareholders, and employees, motivate employees' enthusiasm and creativity, enhance employee cohesion and the company's competitiveness, and promote the long-term, sustainable, and healthy development of the company.

CMOC Group Limited (03993) announced its interim results, with a net profit attributable to shareholders of approximately 16.152 billion yuan, representing a year-on-year increase of 86.27%. A dividend of 0.95 yuan is proposed for every 10 shares.

Growth momentum continues: "Africa's first consumer goods manufacturing stock" SOFTCARE (02698) accelerates market expansion in the mid-term, with profits increasing by 46% and a dividend payout ratio of 66%.

Jiangsu Hengrui Pharmaceuticals (01276): Tian Fei has been appointed as the Secretary of the Board.